Products sit on shelves with virtually no federal regulation governing their potency
Across nearly every state, the officials charged with enforcing the law have arrived at the same conclusion: a loophole written into federal agricultural policy has quietly become a pipeline for unregulated intoxicants, and children are paying the price. Thirty-nine attorneys general have formally asked Congress to close the gap left by the 2018 Farm Bill, which inadvertently permitted hemp-derived THC products to multiply beyond any meaningful oversight. The appeal is less a political maneuver than a reckoning — a moment when the distance between legislative intent and lived consequence has grown too wide to ignore.
- Children as young as toddlers are arriving in emergency rooms with seizures, racing hearts, and altered mental states after ingesting hemp-derived THC products bought at gas stations or ordered online.
- Poison control centers are documenting a sharp and accelerating rise in exposure calls, transforming what regulators once treated as a gray-area nuisance into a documented public health emergency.
- The products exist in a regulatory void — not approved by the FDA, inconsistently banned or permitted by states, and sold with virtually no age verification or reliable labeling of potency.
- Thirty-nine state attorneys general have sent a coordinated formal request to Congress, demanding federal standards for testing, labeling, age restrictions, and enforceable consequences for violators.
- Whether Congress responds hinges on whether lawmakers recognize this as a health crisis rather than a jurisdictional dispute — and the attorneys general warn that delay means more children in emergency rooms.
Thirty-nine state attorneys general have formally asked Congress to close a regulatory gap in the hemp industry that has allowed THC-containing products to spread with almost no oversight, age restrictions, or accountability. The harm is not theoretical — pediatric emergency rooms are seeing children arrive with seizures, rapid heart rates, and altered mental states, while poison control centers report a sharp rise in exposure calls. The pattern is widespread enough that law enforcement officials across nearly every state have moved in unison.
The legal origin of the problem lies in the 2018 Farm Bill, which legalized hemp-derived cannabinoids as a carve-out from marijuana regulation. Manufacturers seized on this distinction aggressively, flooding gas stations, vape shops, and online retailers with products containing delta-8 THC, delta-10 THC, and other synthetic compounds — marketed variously as wellness aids or recreational intoxicants, with no federal body governing their potency, purity, or marketing claims.
The regulatory landscape compounds the danger. The FDA has not classified these products as supplements or medications. State responses range from outright bans to complete inaction. Labels may misrepresent actual THC content, and the supply chain remains largely opaque to consumers and authorities alike.
The attorneys general are calling for Congress to establish federal testing and labeling standards, impose age restrictions comparable to those on alcohol and tobacco, and create enforcement mechanisms that give states real authority over manufacturers and retailers. Their request carries the weight of officials who have seen the consequences firsthand — not only in statistics, but in conversations with families. The question now is whether Congress will treat this as the public health matter it has become, or allow the gap to widen further.
Thirty-nine state attorneys general have sent a formal request to Congress asking lawmakers to plug what they describe as a significant regulatory gap in the hemp industry—one that has allowed THC-containing products to proliferate with minimal oversight or age verification. The concern is not abstract. Poison control centers across the country are fielding a rising number of calls related to these products, and pediatric emergency rooms are seeing children arrive with adverse reactions to hemp-derived THC compounds that were purchased with ease, often online or at convenience stores.
The legal architecture that created this situation is straightforward in its perversity. When Congress legalized hemp-derived products through the 2018 Farm Bill, the legislation carved out an exception for cannabinoids derived from hemp rather than marijuana. This distinction, intended to allow for industrial hemp cultivation, opened a door that manufacturers have walked through aggressively. Products containing delta-8 THC, delta-10 THC, and other synthetic or semi-synthetic cannabinoids now sit on shelves in gas stations and vape shops, marketed sometimes as wellness products, sometimes as recreational intoxicants, with virtually no federal regulation governing their potency, purity, or marketing claims.
What makes this a public health emergency rather than merely a regulatory annoyance is the velocity of harm. Children—some as young as toddlers—have ingested these products, either by accident or through deliberate use, and ended up in emergency departments experiencing rapid heart rates, altered mental states, severe nausea, and in some cases, seizures. Poison control centers, which track such exposures, have documented a sharp increase in calls. The attorneys general are not citing isolated incidents; they are describing a pattern that has grown large enough to warrant coordinated action from law enforcement officials across nearly every state.
The problem is compounded by the fact that these products exist in a regulatory no-man's-land. The FDA has not approved them as dietary supplements or medications. State regulations vary wildly—some states have banned them outright, others have imposed age restrictions, and many have done nothing at all. Manufacturers operate with minimal accountability for what goes into their products or how they are marketed. A bottle labeled as containing a certain amount of THC might contain significantly more or less. Products marketed to adults are sold without meaningful age verification. The supply chain is largely opaque.
The attorneys general are asking Congress to clarify the legal status of these hemp-derived cannabinoids, to establish federal standards for testing and labeling, and to impose age restrictions similar to those that govern alcohol and tobacco. They are also calling for enforcement mechanisms that would allow states to take action against manufacturers and retailers who violate whatever new rules are established. The request carries weight because it comes from law enforcement officials who are seeing the consequences firsthand—not just in poison control statistics, but in conversations with parents whose children have been harmed.
What happens next depends on whether Congress treats this as a genuine public health matter or as a regulatory turf war between federal agencies and state governments. The attorneys general have made their position clear: the current situation is untenable. The question now is whether lawmakers will act before more children end up in emergency rooms.
Notable Quotes
The attorneys general are asking Congress to clarify the legal status of these hemp-derived cannabinoids and establish federal standards for testing and labeling— The 39 state attorneys general
The Hearth Conversation Another angle on the story
Why did Congress create this loophole in the first place? Was it intentional?
The 2018 Farm Bill legalized hemp cultivation for industrial purposes, and the language carved out an exception for hemp-derived cannabinoids. The intent was probably legitimate—to allow farmers to grow hemp without federal interference. But manufacturers found a way to exploit that language by creating and selling intoxicating products that technically comply with the letter of the law while violating its spirit.
So these products are legal right now, even though they're causing harm?
In many places, yes. They exist in a gray zone. Some states have banned them, but federally they're unregulated. That's what makes it so dangerous—there's no testing requirement, no potency limit, no age restriction in most jurisdictions. A child can walk into a gas station and buy something that will get them high.
How bad is the data on child exposures?
Bad enough that poison control centers are tracking a surge in calls. Emergency rooms are seeing children with serious symptoms—rapid heartbeat, confusion, seizures. These aren't rare events anymore. They're frequent enough that nearly 40 state attorneys general felt compelled to act in concert.
What do the attorneys general actually want Congress to do?
Clarify the law so these products are either banned or heavily regulated. Set federal standards for testing and labeling. Impose age restrictions. Give states enforcement tools. Basically, treat hemp-derived THC like any other intoxicant that can harm children.
Is there industry pushback?
Almost certainly, though the source material doesn't detail it. The manufacturers have built a business model on regulatory ambiguity. Clarifying the law would force them to either comply with strict standards or exit the market. That's a powerful incentive to resist.
What's the timeline for congressional action?
Unknown. The attorneys general have made their request, but Congress moves slowly on these issues. In the meantime, children continue to be exposed to products that nobody is really monitoring.